Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

An Intra-Vaginal Zinc Oxide Tetrapod Nanoparticles (ZOTEN) and Genital Herpesvirus Cocktail Can Provide a Novel Platform for Live Virus Vaccine.

Agelidis A, Koujah L, Suryawanshi R, Yadavalli T, Mishra YK, Adelung R, Shukla D.

Front Immunol. 2019 Mar 20;10:500. doi: 10.3389/fimmu.2019.00500. eCollection 2019.

2.

Pathogenesis of herpes simplex keratitis: The host cell response and ocular surface sequelae to infection and inflammation.

Lobo AM, Agelidis AM, Shukla D.

Ocul Surf. 2019 Jan;17(1):40-49. doi: 10.1016/j.jtos.2018.10.002. Epub 2018 Oct 11. Review.

PMID:
30317007
3.

Host Enzymes Heparanase and Cathepsin L Promote Herpes Simplex Virus 2 Release from Cells.

Hopkins J, Yadavalli T, Agelidis AM, Shukla D.

J Virol. 2018 Nov 12;92(23). pii: e01179-18. doi: 10.1128/JVI.01179-18. Print 2018 Dec 1.

4.

An off-target effect of BX795 blocks herpes simplex virus type 1 infection of the eye.

Jaishankar D, Yakoub AM, Yadavalli T, Agelidis A, Thakkar N, Hadigal S, Ames J, Shukla D.

Sci Transl Med. 2018 Feb 14;10(428). pii: eaan5861. doi: 10.1126/scitranslmed.aan5861.

PMID:
29444978
5.

Targeting Herpes Simplex Virus-1 gD by a DNA Aptamer Can Be an Effective New Strategy to Curb Viral Infection.

Yadavalli T, Agelidis A, Jaishankar D, Mangano K, Thakkar N, Penmetcha K, Shukla D.

Mol Ther Nucleic Acids. 2017 Dec 15;9:365-378. doi: 10.1016/j.omtn.2017.10.009. Epub 2017 Oct 17.

6.

Viral Activation of Heparanase Drives Pathogenesis of Herpes Simplex Virus-1.

Agelidis AM, Hadigal SR, Jaishankar D, Shukla D.

Cell Rep. 2017 Jul 11;20(2):439-450. doi: 10.1016/j.celrep.2017.06.041.

7.

Cultured corneas show dendritic spread and restrict herpes simplex virus infection that is not observed with cultured corneal cells.

Thakkar N, Jaishankar D, Agelidis A, Yadavalli T, Mangano K, Patel S, Tekin SZ, Shukla D.

Sci Rep. 2017 Feb 15;7:42559. doi: 10.1038/srep42559.

8.

Cell entry mechanisms of HSV: what we have learned in recent years.

Agelidis AM, Shukla D.

Future Virol. 2015 Oct 1;10(10):1145-1154.

9.

Erratum: The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis.

Onizawa M, Oshima S, Schulze-Topphoff U, Oses-Prieto JA, Lu T, Tavares R, Prodhomme T, Duong B, Whang MI, Advincula R, Agelidis A, Barrera J, Wu H, Burlingame A, Malynn BA, Zamvil SS, Ma A.

Nat Immunol. 2015 Jul;16(7):785. doi: 10.1038/ni0715-785c. No abstract available.

10.

The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis.

Onizawa M, Oshima S, Schulze-Topphoff U, Oses-Prieto JA, Lu T, Tavares R, Prodhomme T, Duong B, Whang MI, Advincula R, Agelidis A, Barrera J, Wu H, Burlingame A, Malynn BA, Zamvil SS, Ma A.

Nat Immunol. 2015 Jun;16(6):618-27. doi: 10.1038/ni.3172. Epub 2015 May 4. Erratum in: Nat Immunol. 2015 Jul;16(7):785.

11.

Heparanase is a host enzyme required for herpes simplex virus-1 release from cells.

Hadigal SR, Agelidis AM, Karasneh GA, Antoine TE, Yakoub AM, Ramani VC, Djalilian AR, Sanderson RD, Shukla D.

Nat Commun. 2015 Apr 27;6:6985. doi: 10.1038/ncomms7985.

12.

Dimerization and ubiquitin mediated recruitment of A20, a complex deubiquitinating enzyme.

Lu TT, Onizawa M, Hammer GE, Turer EE, Yin Q, Damko E, Agelidis A, Shifrin N, Advincula R, Barrera J, Malynn BA, Wu H, Ma A.

Immunity. 2013 May 23;38(5):896-905. doi: 10.1016/j.immuni.2013.03.008. Epub 2013 Apr 18.

Supplemental Content

Loading ...
Support Center